ReNetX Bio
Latest round
- Series A
Last raised
- Apr 2018
Total raised
- $1.7M
Investors
- 2
About ReNetX Bio
Founded in 2010 and based in Connecticut, US, ReNetX Bio, Inc. is a biotechnology that operates as a developer of treatments focusing on injury and damage of the central nervous system such as spinal cord injury, stroke, and glaucoma.
Who invested in ReNetX Bio
2 investors across 1 round
See all investors in ReNetX Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 6, 2018
Amount
$1.7M
Investors
Questions about ReNetX Bio
Who invested in ReNetX Bio?
ReNetX Bio has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ReNetX Bio raised?
ReNetX Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did ReNetX Bio last raise money?
ReNetX Bio's most recent round on record is a Series A, in Apr 2018.
What does ReNetX Bio do?
Founded in 2010 and based in Connecticut, US, ReNetX Bio, Inc.
Where is ReNetX Bio headquartered?
ReNetX Bio is headquartered in New Haven, US.
Which VCs invest in companies like ReNetX Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ReNetX Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like ReNetX Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.